rs1187845779

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001367624.2(ZNF469):​c.1856G>A​(p.Ser619Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000715 in 1,397,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S619I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

ZNF469
NM_001367624.2 missense

Scores

2
6
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.38

Publications

0 publications found
Variant links:
Genes affected
ZNF469 (HGNC:23216): (zinc finger protein 469) This gene encodes a zinc-finger protein. Low-percent homology to certain collagens suggests that it may function as a transcription factor or extra-nuclear regulator factor for the synthesis or organization of collagen fibers. Mutations in this gene cause brittle cornea syndrome. [provided by RefSeq, Jul 2008]
ZNF469 Gene-Disease associations (from GenCC):
  • brittle cornea syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp
  • brittle cornea syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • aortic disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2625298).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF469NM_001367624.2 linkc.1856G>A p.Ser619Asn missense_variant Exon 3 of 3 ENST00000565624.3 NP_001354553.1
ZNF469XM_047434810.1 linkc.1856G>A p.Ser619Asn missense_variant Exon 4 of 4 XP_047290766.1
LOC112268182XR_007065178.1 linkn.250+638C>T intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF469ENST00000565624.3 linkc.1856G>A p.Ser619Asn missense_variant Exon 3 of 3 6 NM_001367624.2 ENSP00000456500.2 H3BS19
ZNF469ENST00000437464.1 linkc.1856G>A p.Ser619Asn missense_variant Exon 1 of 2 5 ENSP00000402343.1 Q96JG9

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
7.15e-7
AC:
1
AN:
1397676
Hom.:
0
Cov.:
62
AF XY:
0.00000145
AC XY:
1
AN XY:
689344
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31594
American (AMR)
AF:
0.00
AC:
0
AN:
35698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25170
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35732
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47722
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
9.27e-7
AC:
1
AN:
1078858
Other (OTH)
AF:
0.00
AC:
0
AN:
57972
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:1
Jan 19, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.S619N variant (also known as c.1856G>A), located in coding exon 1 of the ZNF469 gene, results from a G to A substitution at nucleotide position 1856. The serine at codon 619 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.65
CADD
Uncertain
25
DANN
Uncertain
0.98
DEOGEN2
Benign
0.044
T;.
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.57
T;.
M_CAP
Pathogenic
0.34
D
MetaRNN
Benign
0.26
T;T
MetaSVM
Benign
-1.0
T
PhyloP100
3.4
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.13
Sift
Benign
0.12
T;T
Sift4G
Uncertain
0.012
D;D
Vest4
0.20
MutPred
0.13
Loss of phosphorylation at S619 (P = 0.0039);Loss of phosphorylation at S619 (P = 0.0039);
MVP
0.59
ClinPred
0.85
D
GERP RS
4.5
gMVP
0.12
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1187845779; hg19: chr16-88495734; API